Agreement signedPublished 12 Jun 2026

Aspire Biopharma Holdings, Inc. /
DCS

Aspire agrees to buy automotive systems business for $30 million

Buy side: Aspire Biopharma Holdings, Inc.
Buy sideAspire Biopharma Holdings, Inc.
Target: DCS
TargetDCS
Aspire Biopharma Holdings, Inc. · 12 Jun 2026Source
Buy side: Aspire Biopharma Holdings, Inc.
Buy sideAspire Biopharma Holdings, Inc.
Target: DCS
TargetDCS
01 / BuyerAspire Biopharma Holdings, Inc.
02 / TargetDCS
Source for the buyer and target: Aspire Biopharma Holdings, Inc.

For the buyer and target.

“ESTERO, FL / June 12, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq: ASBP) (“Aspire” or the “Company”), today announced the signing of a definitive Share Purchase Agreement (“SPA”) for the acquisition of 100% of Dura Driver Control Systems (“DCS”), a premier designer and manufacturer of automotive driver control systems with expanding industrial applications.”

Published 12 Jun 2026

Open the source
01

What happened

Aspire Biopharma Holdings, Inc. entered into a purchase agreement with FireFish TopCo, LLC to acquire equity interests and assets tied to a business that designs, manufactures, markets and sells automotive driver control systems. The filing says the Company would pay a purchase price of $30,000,000, plus $800,000 for deferred revenue, subject to adjustments at closing. [01]

The agreement includes an audit condition with an outside date of Sept. 10, 2026, and a termination fee of $3,500,000 in certain circumstances. Aspire's CEO described the deal as an acquisition of DCS, an automotive systems manufacturer. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Aspire Biopharma Holdings, Inc.

Aspire agrees to buy automotive systems business for $30 million

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Aspire Biopharma Holdings, Inc.

    The source this page is built from.

    Open the source
  2. Also stated

    “The agreement includes an audit condition with an outside date of Sept. 10, 2026, and a termination fee of $3,500,000 in certain circumstances”

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealAspire Biopharma Holdings, Inc. / DCSAgreement signed · Published 12 Jun 2026
BuyerAspire Biopharma Holdings, Inc.TargetDCS
This dealAspire Biopharma Holdings, Inc. / DCS

Agreement signed · Aspire Biopharma Holdings, Inc. / DCS deal (Agreement signed, published 12 Jun 2026).

Published 12 Jun 2026
Timeline
  1. Published by Aspire Biopharma Holdings, Inc.
  2. Also stated
Hover or tap a name to see how it connects, and when
Deal Web as a list